http://isrctn.com/ 2021
DOI: 10.1186/isrctn43307947
|View full text |Cite
|
Sign up to set email alerts
|

Expanded access protocol for the use of tecovirimat for the treatment of monkeypox infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Vaccination with vaccinia vaccine is not recommended for those with certain medical conditions, including severe allergies, immunosuppression, pregnancy, breastfeeding, preexisting heart disease, and a background of atopic dermatitis (AD) or the other exfoliative skin disease. 74,75 Alternative suggested treatment includes administration of antiviral like tecovirimat which is approved antiviral in the treatment of smallpox, particularly adults patients. Antiviral brincidofovir, used for treating severe smallpox viruses for both children and adults, is undergoing evaluation for EA-IND used in treating monkeypox.…”
Section: First Line Defencementioning
confidence: 99%
“…Vaccination with vaccinia vaccine is not recommended for those with certain medical conditions, including severe allergies, immunosuppression, pregnancy, breastfeeding, preexisting heart disease, and a background of atopic dermatitis (AD) or the other exfoliative skin disease. 74,75 Alternative suggested treatment includes administration of antiviral like tecovirimat which is approved antiviral in the treatment of smallpox, particularly adults patients. Antiviral brincidofovir, used for treating severe smallpox viruses for both children and adults, is undergoing evaluation for EA-IND used in treating monkeypox.…”
Section: First Line Defencementioning
confidence: 99%